title: Comparing ablative fractionated resurfacing, photodynamic therapy, and topical imiquimod in the treatment of trichoblastomas of Brooke-Spiegler Syndrome: a case study.
authors.affiliation: Department of Dermatology, Henry Ford Health System, Detroit, Michigan 48377, USA.
authors.forename: Matteo C
authors.initials: MC
authors.lastname: LoPiccolo
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Sage
authors.forename: David J
authors.initials: DJ
authors.lastname: Kouba
mesh_terms: D000622:Aminolevulinic Acid / Q000627:therapeutic use*; D000634:Aminoquinolines / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use; D003528:Carcinoma, Adenoid Cystic / Q000188:drug therapy / Q000601:surgery; D018280:Carcinoma, Skin Appendage / Q000188:drug therapy / Q000601:surgery; D003131:Combined Modality Therapy; D006801:Humans; D000077271:Imiquimod; D053844:Lasers, Solid-State / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009386:Neoplastic Syndromes, Hereditary / Q000188:drug therapy / Q000601:surgery; D010778:Photochemotherapy; D017319:Photosensitizing Agents / Q000627:therapeutic use; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000601:surgery*; D016896:Treatment Outcome
chemical_list: D000634:Aminoquinolines; D000970:Antineoplastic Agents; D017319:Photosensitizing Agents; D000622:Aminolevulinic Acid; D000077271:Imiquimod